Don’t miss out - Get your tickets early!

Join this FREE WEBINAR presented by Dr Macsue Jacques and Dr Louise Hecker (USA).

TOPIC: Can Psilocybin Improve Human Health Span and the Biology of Ageing?

This webinar will examine psilocybin research through a geroscience and systems biology lens, focusing on what psychedelic-induced distress can reveal about fundamental ageing processes across biological systems and how and why psilocybin may improve human life and health span.

Key Learning Outcomes:

Understand ageing as a progressive loss of biological plasticity and adaptive capacity across molecular, cellular, and systemic levels.
Review the first evidence demonstrating that psilocybin impacts ageing biology, and explore the mechanisms through which it engages conserved pathways such as inflammation, stress response, metabolic regulation, and cellular resilience.
Examine how psilocybin influences systemic organ systems, highlighting cross-tissue and whole-body effects.
Discuss the use of psilocybin as an experimental probe and its potential as a geroprotective agent, with relevance to flexibility, recovery, and biological reprogramming in ageing systems.
Consider implications for healthspan science, emphasising restoration of adaptability and integrative, cross-tissue frameworks beyond single-organ models.

EVENT DETAILS

DATE: 4th March 2026
TIME: 11:55am (AEDT) for 12:00pm start, finishing at 1:15pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online - a link will be emailed to you with the viewing details

A replay of the event will be made available on our YouTube channel.

ABOUT THE PRESENTER

Dr Louise Hecker (USA)

Clinical Associate Professor: Medicine - Cardiovascular Research, Baylor College of Medicine

Louise Hecker, PhD is an Associate Professor at Baylor College of Medicine and the Founder and Chief Scientific Officer at Fibronox with over 15 years of experience in regenerative biology, fibrosis research, and age-related disease therapeutics. She is a world-leading expert on Nox4 and Nrf2, having made numerous seminal discoveries in understanding how oxidative stress contributes to tissue fibrosis and ageing.

Her groundbreaking research has revolutionized the understanding of fibrotic diseases and recently expanded into psychedelic medicine, where her team discovered that psilocybin extends cellular lifespan by up to 57% and improves survival in aged mice. As an academic entrepreneur, she has founded five companies and secured approximately $15 million in research funding as Principal Investigator while holding around 20 patent applications.

Dr Macsue Jacques
Postdoctoral Researcher at Monash University

Dr Macsue Jacques is a prominent postdoctoral researcher and data scientist specializing in aging, epigenetics, and longevity science. Based at the Australian Regenerative Medicine Institute (ARMI) at Monash University, she focuses on utilizing multi-omics approaches and advanced computational tools to understand the mechanisms of aging.

---

MEDICINAL PSYCHEDELIC TREATMENTS

Psychedelic-assisted treatments offer enormous potential in providing a meaningful alternative to current treatments for mental illness. PTSD is a debilitating condition that affects tens of millions of people worldwide, with many more trauma victims diagnosed with comorbid conditions such as depression, anxiety and eating disorders. In recent clinical trials, MDMA has been shown to produce reliable clinical improvements, restoring patient safety and self-agency even for individuals who have suffered with PTSD for many years, and for whom many treatments have failed.

The wave of clinical psychedelic research and regulatory support is rapidly building, with experts forecasting the availability of psychedelic-assisted treatments in the US and EU within the next 2 to 5 years, subject to positive clinical outcomes in large trials that are currently underway.

SUPPORT PSYCHEDELIC RESEARCH AND THERAPY DEVELOPMENT

Your donation to Mind Medicine Australia will help us accelerate the availability and best practice of psychedelic-assisted psychotherapy in Australia. We are a small organisation doing big things – we need your support. Please click here to make a tax-deductible donation.

DISCLAIMER

Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms i.e. Facebook, Instagram or zoom private and public chat forms during the webinar. Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters. Mind Medicine Australia is focused specifically on the clinical application of medicinal psilocybin and medicinal MDMA for certain mental illnesses.

Contact the host of Mind Medicine Australia FREE Webinar: Can Psilocybin Improve Human Health Span and the Biology of Ageing? with Dr Louise Hecker (USA) and Dr Macsue Jacques

There were 0 errors found in the information you submitted: